FindTrial
Sign In

Combined intervention of omega-3 fatty acids and vitamin D in patients with Hashimoto's thyroiditis.

A randomized controlled trial of combined intervention of Omega-3 fatty acids and vitamin D in patients with Hashimoto's thyroiditis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046558
Enrollment
Unknown
Registered
2021-05-21
Start date
2021-06-06
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis

Interventions

Omega-3 fatty acid group A:Omega-3 PUFA
Omega-3 fatty acid group B:Omega-3 PUFA+VitaminD
Vitamin D group C:Vitamin D
Placebo group D:Placebo
Healthy control group H:None

Sponsors

Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 67 Years

Inclusion criteria

Inclusion criteria: 1.Positive serum thyroglobulin antibody (> 115IU/mL) or serum thyroid peroxidase antibody (> 34IU/mL); 2.The presence of euthyroidism; 3.Hypoechoic thyroid parenchyma by ultrasonography.

Exclusion criteria

Exclusion criteria: 1. During pregnancy and lactation; 2. Alcohol addiction; 3. Dyslipidemia; 4. Impaired renal function or liver function; 5. Any other serious diseases; 6. Known history of autoimmune diseases; 7. Those who have participated in other drug clinical research in the past three months; 8. The researcher believes that it is not suitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
thyroid peroxidase antibody;thyroglobulin antibody;—

Countries

China

Contacts

Public ContactLi Jiaomei

Qingdao University

jiaomeili90@163.com+86 18158519707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026